NTHI Stock

Profile

Full Name:

NEONC TECHNOLOGIES HOLDINGS, INC.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

Indexes:

Not included

Website:

http://www.neonctech.com

Description:

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

Key Details

Price

-

Market Cap

-

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$20.00 K(+100.00% YoY)

Annual EPS

-$0.15(+9.71% YoY)

PE Ratio

-

Annual ROE

193.39%

Annual Debt To Equity

-0.03

Beta

-

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

N/A

Recent annual earnings:

N/A
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with NTHI included

No data

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price All-time High

$0.00
NTHI price is currently at an all-time high

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Revenue 3-Year Change

+100%
NTHI annual revenue is up +100% over the past 3 years

Annual Net Income 3-Year Change

+9.74%
NTHI annual net profit is up +9.74% over the past 3 years

Annual EPS 3-Year Change

+9.71%
NTHI annual earnings per share is up +9.71% over the past 3 years

Annual Operating Profit

-$2.84 M
NTHI annual operaing income is -$2.84 million

Annual Operating Profit 3-Year Change

+13.27%
NTHI annual operaing income is up +13.27% over the past 3 years

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual ROE

193.39%
NTHI annual return on equity is 193.39%

Annual ROA

-418.12%
NTHI annual return on assets is -418.12%

Annual EBIT

-$2.85 M
NTHI annual earnings before interest & taxes is -$2.85 million

Annual EBITDA

-$2.85 M
NTHI annual earnings before interest, taxes, depreciation & amortization is -$2.85 million

Annual Interest Coverage Ratio

-14.22
NTHI annual interest coverage ratio is -14.22

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Current Ratio

0.32
NTHI annual current ratio is 0.32

Annual Total Assets

$728.68 K
NTHI annual total assets is $728.68 thousand

Annual Current Assets

$728.68 K
NTHI annual total current assets is $728.68 thousand

Annual Total Liabilities

$2.30 M
NTHI annual total liabilities is $2.30 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual CFO 3-Year Change

-122.27%
NTHI annual cash flow from operations is down -122.27% over the past 3 years

Annual CFF 3-Year Change

+496%
NTHI annual cash flow from financing activities is up +496% over the past 3 years

Annual FCF

-$881.74 K
NTHI annual free cash flow is -$881.74 thousand

Annual FCF 3-Year Change

-122.27%
NTHI annual free cash flow is down -122.27% over the past 3 years

Institutional Ownership

Similar stocks

FAQ

  • What is the primary business of NEONC TECHNOLOGIES HOLDINGS?
  • What is the ticker symbol for NEONC TECHNOLOGIES HOLDINGS?
  • Does NEONC TECHNOLOGIES HOLDINGS pay dividends?
  • What sector is NEONC TECHNOLOGIES HOLDINGS in?
  • What industry is NEONC TECHNOLOGIES HOLDINGS in?
  • What country is NEONC TECHNOLOGIES HOLDINGS based in?
  • Is NEONC TECHNOLOGIES HOLDINGS in the S&P 500?
  • Is NEONC TECHNOLOGIES HOLDINGS in the NASDAQ 100?
  • Is NEONC TECHNOLOGIES HOLDINGS in the Dow Jones?
  • When does NEONC TECHNOLOGIES HOLDINGS report earnings?

What is the primary business of NEONC TECHNOLOGIES HOLDINGS?

Neonc Technologies Holdings, Inc. develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

What is the ticker symbol for NEONC TECHNOLOGIES HOLDINGS?

The ticker symbol for NEONC TECHNOLOGIES HOLDINGS is NASDAQ:NTHI

Does NEONC TECHNOLOGIES HOLDINGS pay dividends?

No, NEONC TECHNOLOGIES HOLDINGS does not pay dividends

What sector is NEONC TECHNOLOGIES HOLDINGS in?

NEONC TECHNOLOGIES HOLDINGS is in the Healthcare sector

What industry is NEONC TECHNOLOGIES HOLDINGS in?

NEONC TECHNOLOGIES HOLDINGS is in the Biotechnology industry

What country is NEONC TECHNOLOGIES HOLDINGS based in?

NEONC TECHNOLOGIES HOLDINGS is headquartered in United States

Is NEONC TECHNOLOGIES HOLDINGS in the S&P 500?

No, NEONC TECHNOLOGIES HOLDINGS is not included in the S&P 500 index

Is NEONC TECHNOLOGIES HOLDINGS in the NASDAQ 100?

No, NEONC TECHNOLOGIES HOLDINGS is not included in the NASDAQ 100 index

Is NEONC TECHNOLOGIES HOLDINGS in the Dow Jones?

No, NEONC TECHNOLOGIES HOLDINGS is not included in the Dow Jones index

When does NEONC TECHNOLOGIES HOLDINGS report earnings?

The date for NEONC TECHNOLOGIES HOLDINGS's next earnings report has not been announced yet